We are thrilled to announce the appointment of Scott Burrows to the role of Chief Financial Officer and Heidy Abreu King-Jones to the role of Chief Legal Officer and Corporate Secretary of Aeglea Therapeutics. These professionals bring a wealth of experience and knowledge to the team, and we are looking forward to working with them to change the landscape of treatment for #IBD. Scott comes to Aeglea with a proven track-record in the #biopharmaceutical finance space, having worked in various leadership roles for more than two decades. Most recently, he served as the CFO for Arcutis Biotherapeutics, where he led the team through a successful IPO and ultimately enabled the smooth transition to a commercial-stage company. Heidy is also an industry veteran, having most recently served as the CLO and Corporate Secretary at Provention Bio. In this role, she navigated a number of milestones, including various financings, the approval of Tzield®, the company's successful transition from clinical-stage to commercial-stage, and ultimately the company's acquisition by Sanofi.We know that both Scott and Heidy will further enhance the caliber of Aeglea's leadership team, and we are excited to work alongside them to revolutionize treatment of IBD. Welcome to the team! #monoclonalantibody #biotech #biopharma
About us
With its acquisition of Spyre Therapeutics, Aeglea is shifting its disease focus to inflammatory bowel disease (IBD). Spyre combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for IBD. For more information, please visit http://aeglea.com.
- Website
-
http://www.aeglea.com
External link for Aeglea BioTherapeutics
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Austin, Texas
- Type
- Public Company
- Founded
- 2013
- Specialties
- biotech, biotechnology, rare disease, human enzymes, and engineering enzymes
Locations
-
Primary
Get directions
805 Las Cimas Pkwy
Suite 100
Austin, Texas 78746, US
Employees at Aeglea BioTherapeutics
-
Gail Lawrence
Contract CRA at Aeglea BioTherapeutics
-
Gillian Bubb
Senior Director Clinical Science, Clinical Development, Rare Genetic Disease. at Aeglea BioTherapeutics
-
Akeem Mustapha
Associate Director, Clinical Data Management at Aeglea BioTherapeutics
-
Jo O'Keefe
Clinical Project Manager